Belgium· BE-AMP-SAM362311-00
Scintimun 1 mg
A 99mtc-technetium-antigranulozyten antikörper product containing besilesomab, registered in Belgium by Telix Innovations. The same ATC class is registered in 9 of our 19 countries.
Checked against FAMHP / AFMPS (Belgium) on
Informational only — not a medical device.
Where it is registered
99mtc-technetium-antigranulozyten antikörper is registered in 9 of 19 countries.
Countries holding a registration under ATC V09HA03 (99mtc-technetium-antigranulozyten antikörper), each read from that country’s own register.
- This record: Belgium, from FAMHP / AFMPS (Belgium)
- 6 of them publish a price we can compare per daily dose
99mtc-technetium-antigranulozyten antikörper · ATC V09HA03
9 / 19 countries
- Belgiumprice
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Netherlands
- Polandprice
- Switzerlandprice
The record
At a glance
FAMHP / AFMPS (Belgium)- Active substance
- Besilesomab
- Manufacturer
- Telix Innovations
- Country
- Belgium (BE)
- ATC code
- V09HA03
- ATC class
- 99mTc-Technetium-Antigranulozyten Antikörper
- Reimbursed
- Not published by this register
- Source register
- FAMHP / AFMPS (Belgium)
- Last checked
- September 26, 2026
Packs & prices · 1
- be_apb4834446
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
99mtc-technetium-antigranulozyten antikörper in 11 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaSCINTIMUNTelix Innovations, Herstal
- SpainSCINTIMUN 1 mg, EQUIPO DE REACTIVOS PARA PREPARACION RADIOFARMACEUTICATelix Innovations
- United KingdomScintimun 1mg kit for radiopharmaceutical preparationCurium Pharma UK Ltd
- PolandScintimunTelix Innovations
- SwedenScintimun 1 mg Beredningssats för radioaktivt läkemedelTelix Innovations
- FinlandScintimunTelix Innovations
- FranceSCINTIMUN 1 mg trousse pour préparation radiopharmaceutiqueTELIX INNOVATIONS (BELGIQUE)
- IrelandScintimun 1 mg kit for radiopharmaceutical preparationTelix Innovations
Authorised across Europe · EMA
The same active substance is authorised in 3 EEA countries. Names it is sold under:
- Iceland · Scintimun
- Liechtenstein · Scintimun
- Norway · Scintimun
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FAMHP / AFMPS (Belgium). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/de3895c3-2ae5-44b1-b586-865d8b22b616 GET /v1/drugs/de3895c3-2ae5-44b1-b586-865d8b22b616?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Kit for radiopharmaceutical preparation",
"source": "afmps",
"status": "AUTHORIZED",
"name_en": "Scintimun 1 mg",
"name_fr": "Scintimun 1 mg",
"name_nl": "Scintimun 1 mg",
"amp_code": "SAM362311-00",
"strengths": [
"1.0000",
"1.0000"
],
"pack_count": 2,
"substances": [
"Besilesomab",
"Disodium Hydrogen Phosphate Anhydrous",
"Sodium Dihydrogen Phosphate Anhydrous",
"Sodium Hydroxide",
"Sorbitol"
],
"medicine_type": "ALLOPATHIC",
"atc_description": "Technetium (99mTc) Antigranulocyte Antibody",
"authorisation_numbers": [
"EU/1/09/602/002",
"EU/1/09/602/001"
]
}See everything about 99mtc-technetium-antigranulozyten antikörper.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.